Blood test may uncover hidden cancers in nerve disorder patients

NCT ID NCT07491328

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a special blood test (liquid biopsy) can find tumor cells in people with paraneoplastic neurological syndromes (PNS), a condition where the immune system attacks the nerves due to an undetected cancer. Researchers will collect blood from 60 participants, including those with PNS and known tumors, those with PNS but no known tumor, and cancer patients without PNS. The goal is to improve early cancer detection in these patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARANEOPLASTIC NEUROLOGICAL SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neoplastic Cells, Circulating paraneoplastic neurologic syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Neurology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf

    RECRUITING

    Düsseldorf, 40225, Germany